Title: Healthcare Industry Australia
1Medical Devices Market Growth Australia
2All the chronic diseases in Australia are
accompanied with long lasting conditions and
persistent effects. Major chronic diseases in
Australia are arthritis, asthma, back pain,
cancer, cardiovascular disease, chronic
obstructive pulmonary disease, diabetes and
mental health conditions, osteoporosis, other
musculoskeletal diseases, chronic kidney disease,
oral diseases such as tooth decay and gum
disease. Modernization over the last few years
has led to increase in the chronic diseases which
are a burden to the Australian population. In
addition to the diseases, consumers are affected
by the health-care costs and loss of productive
work due to illness. Australian health system is
focused on prevention and better management of
chronic disease to improve health outcomes.
3According to the study Australia Infusion
Systems Market Outlook to 2023, infusion pumps
are medical devices used in healthcare facilities
to inject fluids such as drugs, nutrients, and
blood in a controlled systematic manner. Infusion
systems are identified as the fundamental devices
in the healthcare and life sciences industry. The
increase in diseases and patients has led to the
increase in the utility of the infusion pumps at
hospitals, Ambulatory surgical centres (ASCs),
and physicians offices. The infusion pumps
market has witnessed a steady growth due to the
presence of numerous vendors in local and
international markets. To improve their market
positions, the global manufacturers of infusion
pumps are investing in research and development,
and technological innovations. The global leading
players of infusion pumps are BD, Medtronic,
Smiths Medical, Flowonix Medical, InfuSystem,
Moog, Medovex, and Zimmer Biomet.
4Large hospitals in Australia are merged with
medium and small hospitals to enhance the quality
of medical treatment by increasing the number of
skilled medical professionals. This merging
improves capital investment, technology, and
infrastructure of the small hospitals. These
improvements in the hospitals will increase the
number of patients, provides complicated
treatments, and surgeries that need the infusion
of drugs and fluids such as blood and nutrients.
Therefore, majority of the Australian hospitals
would demand for infusion systems and will
witness a steady growth in the infusion pumps
category. The various infusion systems are
injection port, IV cables, and syringes. The
major drawbacks in the infusion systems are air
embolism, infiltration, hematoma, and dose error,
which will impact the growth of infusion systems.
5The infusion systems market is segmented into
Ambulatory Infusion Pumps, Enteral Infusion
Pumps, Implantable Infusion Pumps, Infusion
Disposable Set, Syringe Pumps and Volumetric
Pumps. The leading players in Australian infusion
systems market are Hospira Inc, Becton Dickinson
and Co, Baxter International Inc and Medtronic
plc. Majority of the infusion systems
manufacturers in Australia depend on improved
technologies, high-quality products, and brand
image to raise their revenue. It was observed
that modernization and increase in lifestyle
diseases will drive the growth of the infusion
systems market in Australia over the coming
years.
6To know more, click on the link
below https//www.kenresearch.com/healthcare/medi
cal-devices/australia-infusion-systems-market/1359
63-91.html Related Reports BRIC Infusion
Systems Market Outlook to 2023 India Infusion
Systems Market Outlook to 2023 Contact UsKen
ResearchAnkur Gupta, Head Marketing
CommunicationsAnkur_at_kenresearch.com91-901537824
9
7(No Transcript)